Company

The Radiopharmaceutical industry leader in Korea
A fast growing biotech company with proven records

History

  • 2012 04. Acquired CICO Healthcare (Diagnostic Reagent Distributor)
  • 2011 02. Established a Radiopharmaceutical manufacturing facility in Chilgok-Kyungpook National University Hospital
  • 2010 11. Acquired Radiopharmaceutical manufacturing facilities (Incheon St. Mary’s Hospital, Daejeon Eulji Hospital) from DK Medical Systems Co.
    05. Established a Radiopharmaceutical production facility in Hanyang University Medical Center
  • 2009 09. Acquired a Radiopharmaceutical manufacturing facility in Kangwon National University Hospital
  • 2007 12. Company name changed from Med.ic.boss to DuChemBio
  • 2002 11. Established Med.ic.boss (Health functional food distribution company)
  • 2018 12. Successful ‘Technology Evaluation’ for KOSDAQ listing
    10. Received Korean National Award from Ministry of Trade, Industry and Energy for FP-CIT technology
    07. FES licensing agreement with Asan Medical Center
    01. M&A with Radiopharmaceutical Business Department of Nambuk Medical Appliance. (Acquisition of Radiopharmaceutical and business rights in Gangnam Severance, Daejeon St. Mary's Hospital)
  • 2017 12. GMP certification: Radiopharmaceutical production facility in Hanyang University Medical Center
    11. Signed a manufacturing technology licensing agreement of Bombesin diagnostic & therapeutic agents for prostate cancer with Korea Atomic Energy Research Institute (KAERI)
    09. GMP certification: Radiopharmaceutical production facility in Sinchon Severance Hospital
    08. Won the ‘New Technology Award of the Month’ by Ministry of Trade, Industry & Energy (Development of Manufacturing Technology / Cassette for FP-CIT Overseas Export)
    06. Conclusion of exclusive licensing agreement with Cerecin (former Accera) for a medical food for improvement of cognitive function
    06. World's first licensing-out agreement for FP-CIT with Cyclotek (Australia, New Zealand)
  • 2016 12. Signed a FP-CIT sub-licensing agreement with LMI (former Piramal) (DuChembio owns all FP-CIT license & rights for export)
    07. GMP certification: Radiopharmaceutical production facility in Chilgok-Kyungpook National University Hospital
    07. FP-CIT licensing agreement with Asan Medical Center (Acquiring patent rights for FP-CIT licensing)
    06. CICO Healthcare signed agreement to transfer F-DOPA patent ownership from Asan Medical Center (World’s first neutralization technology)
  • 2014 12. Listed on the KONEX (Korea New Exchange) stock market
    12. Established DuChemBio Research Institute, a joint research center with Korea Atomic Energy Research Institute
    11. NDA approval in Korea: Neuraceq, dementia diagnostic agent
  • 2013 11. Conclusion of an exclusive licensing agreement with LMI (former Piramal) for the development & commercialization of Neuraceq in Korea
    10. Korea-Spain joint research (~ October, 2016) (R&D of FP-CIT & FES cassettes for export)
    06. Launched Radiopharmaceutical business in NKTI Hospital, Manila, Philippines (1st commercial production of radiopharmaceuticals in the Philippines)
    05. Established a Radiopharmaceutical production facility in Sinchon Severance Hospital
  • 2019 10. Acquring approval of F-DOPA with the world’s first neutralization technology
    08. Exclusive licensing agreement for domestic development and commercialization of Solucin with Isotope Technologies Munich (ITM, Germany)
    07. GMP renewal certification: Radiopharmaceutical production facility in Chilgok-Kyungpook National University Hospital
    07. Exclusive licensing agreement with Life Molecular Imaging (LMI, Germany) for the manufacturing & supply of Neuraceq in the Philippines
    07. Signed a manufacturing agreement with KHealth (DuchemBio subsidiary in the Philippines) for FP-CIT, FES and F-DOPA
    06. Exclusive licensing agreement for the domestic development and commercialization of FACBC for Prostate cancer diagnosis with Nihon Medi Physics (NMP, Japan)

그누보드5
Address 4F, 47, Kyonggidae-ro, Seodaemun-gu, Seoul, Republic of Korea [03752]
Tel 02 332 4868 Fax 02 323 3437

Copyright © 2019 Duchembio, Inc. All Rights Reserved